跳至主要内容
临床试验/NCT02831192
NCT02831192已完成2 期

International Multi-center Clinical Study on Microtransplantation for Treatment of Newly Diagnosed Elderly Acute Myeloid Leukemia (EAML)

The Affiliated Hospital of the Chinese Academy of Military Medical Sciences1 个研究点 分布在 1 个国家目标入组 150 人开始时间: 2006年5月1日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
150
试验地点
1
主要终点
Graft versus host disease

研究概览

简要总结

The purpose of this study is to see whether HLA-mismatched donor cells infusion with chemotherapy (microtransplantation,MST) could increase complete remission (CR) and improve survival in older patients with acute myeloid leukemia (AML),the investigators conducted a prospective, multicenter clinical trial of HLA-mismatched MST to estimate outcomes and toxicities.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
60 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • de novo acute myeloid leukemia
  • age 60-90
  • have HLA mismatched donor

排除标准

  • have no suitable donor or donor refused
  • patient refused to accept donor cells

结局指标

主要结局

Graft versus host disease

时间窗: 1 month

次要结局

  • leukemia free survival(2 years)
  • complete remission rate(2 months)
  • overall survival(2 years)

研究者

发起方
The Affiliated Hospital of the Chinese Academy of Military Medical Sciences
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验